by Richard Daverman, PhD
March 12, 2014 -- Hainan Haiyao, a pharma that makes both chemical drugs and TCM products, will invest $20 million in a pharma-focused venture capital JV. Hainan Haiyao will own 49% of the JV, which will be called the Hainan Huantai Bio-Pharmaceutical Investment Fund. The fund will be capitalized with $40.7 million. It will seek investments in early and mid-stage pharmaceutical companies. More details....
Stock Symbol: (SHE: 000566)
Help employers find you! Check out all the jobs and post your resume
